The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11,375.00
Bid: 11,200.00
Ask: 11,550.00
Change: -100.00 (-0.88%)
Spread: 350.00 (3.125%)
Open: 11,275.00
High: 11,200.00
Low: 11,200.00
Prev. Close: 11,300.00
JDG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Update

20 May 2020 07:00

RNS Number : 4081N
Judges Scientific PLC
20 May 2020
 

Judges Scientific plc

("Judges Scientific", "Judges", the "Company" or the "Group")

AGM Update

Judges Scientific, the group focused on acquiring and developing companies in the scientific instrument sector, today provides the following update ahead of its AGM which is being held in St John's Wood, London today at 12.00 noon.

Update on Trading

Across the Group, organic order intake as of 15 May was down 18.5% compared to the same period in 2019, caused by the closure of universities, the cancellation of scientific conferences and our inability to travel. This reduction in order intake has not been evenly spread across our key geographies with China/Hong Kong and the UK each decreasing 4%, North America experiencing a reduction of 25%, the Rest of the World reducing by 22%, whilst Rest of Europe decreased 11%. However, the order book is still comfortable and as at 30 April 2020 stood at 11.9 weeks.

While the prohibition on travel has interfered with our ability to crystallise orders and perform installations, the crisis has also stimulated our businesses to make better use of online alternatives and has given some engineering teams additional time to progress their R&D projects uninterrupted.

The Group has operated profitably in each of the first four months of this year and has generated positive operating cash-flow for the period. As a result, the Group has maintained a robust balance sheet with solid liquidity.

Operational Update

Throughout these unprecedented times, the main priority for the Group has been to protect the safety of our colleagues. Whilst approximately half of our staff are working from home, thanks to the Group's decentralised structure, our businesses have been able to put in place highly tailored and specific logistical solutions to allow manufacturing to continue throughout the crisis, whilst continuing to adhere to the UK government's rules and guidelines around social distancing and hygiene.

Despite the challenges faced, the Group has only suffered minor supply chain issues, all of which have been mitigated and managed accordingly. As noted above customer closures have resulted in a minority of deliveries being postponed.

Management actions taken to mitigate the impact of COVID-19

The Board of Judges believe that it is important to take prudent steps to ensure the business remains well placed to deliver shareholder value. These include:

· In parallel with its staff all Judges directors (including non-executives) reduced their fixed remuneration in proportion to the reduction suffered by the other employees;

· Approximately 20% of our workforce have been furloughed; and

· Lloyds Bank has agreed to repurpose £5 million of our acquisition line into a working capital facility to further buttress our position.

Outlook

The Board continues to believe that the Group is in a robust position to weather the impact of the pandemic.

The COVID-19 crisis has created significant and open-ended global uncertainty, with an associated impact on economic activity. It remains to be seen where and when demand, deliveries and installations will return to normal levels as each jurisdiction in which the Group operates is working independently according to that country's needs. The Board will provide a further update to its trading, in the ordinary course, in its July trading update covering the period to 30 June 2020.

 

For further information please contact:

Judges Scientific

 

 

David Cicurel, CEO

Brad Ormsby, Group FD

Tel: +44 (0) 20 3829 6970

 

 

Shore Capital (Nominated Adviser & Joint Broker)

 

Stephane Auton

Edward Mansfield

Sarah Mather

Tel: +44 (0) 20 7408 4090

 

 

Liberum (Joint Broker)

 

Bidhi Bhoma

Euan Brown

 

 

 

Tel: +44 (0) 20 3100 2222

 

Media enquiries:

Alma PR (Financial Public Relations)

 

Rebecca Sanders-Hewett

Sam Modlin

 

Tel: +44 (0) 20 3865 4219

judges@almapr.co.uk

 

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group involved in the buy and build of scientific instrument businesses. The Group consists of 17 businesses acquired since it was re-admitted to AIM in 2005.

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, the scientific communities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group companies hold five Queen's Awards for innovation and export.

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the repayment of debt, organic growth and dividends.

For further information, please visit www.judges.uk.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDALMMTMTIBTBM
Date   Source Headline
7th Jan 20217:00 amRNSTrading Statement and Notice of Final Results
31st Dec 20207:00 amRNSTotal Voting Rights
10th Dec 20207:00 amRNSDirector/PDMR Shareholding
16th Nov 20207:00 amRNSBlock listing Interim Review
12th Nov 20207:00 amRNSCORRECTION: Director/PDMR Shareholding
11th Nov 20204:48 pmRNSDirector/PDMR Shareholding
10th Nov 20207:00 amRNSDirector/PDMR Shareholding
3rd Nov 20207:00 amRNSGrant of Options
26th Oct 20205:16 pmRNSExercise of Options and Director Dealing
19th Oct 20204:38 pmRNSDirector/PDMR Shareholding
19th Oct 20207:00 amRNSAcquisition of Korvus Technology Ltd
7th Oct 20209:33 amRNSDirector/PDMR Shareholding
22nd Sep 20207:00 amRNSInterim Results
16th Sep 20202:17 pmRNSHolding(s) in Company
10th Sep 202011:25 amRNSDirector/PDMR Shareholding
10th Sep 20207:00 amRNSBoard Change
1st Sep 20209:48 amRNSTotal Voting Rights
11th Aug 20208:24 amRNSDirector/PDMR Shareholding
31st Jul 20207:00 amRNSTotal Voting Rights
21st Jul 20207:00 amRNSTrading Update and Notice of Interim Results
7th Jul 20202:28 pmRNSDirector/PDMR Shareholding
30th Jun 20207:00 amRNSTotal Voting Rights
8th Jun 20204:03 pmRNSDirector/PDMR Shareholding
2nd Jun 20207:00 amRNSTotal Voting Rights
29th May 20207:00 amRNSAcquisition of Heath Scientific Company Limited
20th May 20201:55 pmRNSResult of AGM
20th May 20207:00 amRNSAGM Update
15th May 20208:53 amRNSBlock listing Interim Review
14th May 20209:52 amRNSAGM Q&A
7th May 20209:59 amRNSDirector/PDMR Shareholding
30th Apr 20209:52 amRNSTotal Voting Rights
28th Apr 20207:00 amRNSNotice of AGM
8th Apr 202010:23 amRNSDirector/PDMR Shareholding
31st Mar 202011:10 amRNSTotal Voting Rights
18th Mar 20207:00 amRNSFinal Results
17th Mar 202011:05 amRNSSecond Price Monitoring Extn
17th Mar 202011:00 amRNSPrice Monitoring Extension
10th Mar 20208:55 amRNSDirector/PDMR Shareholding
24th Feb 20207:00 amRNSStatement regarding COVID-19
7th Feb 20207:00 amRNSDirector/PDMR Shareholding
31st Jan 202010:46 amRNSBlocklisting Application and Total Voting Rights
16th Jan 20203:18 pmRNSExercise of Options and Director Dealing
16th Jan 20207:00 amRNSTrading Statement and Notice of Final Results
13th Jan 20209:37 amRNSDirector/PDMR Shareholding
2nd Jan 20201:42 pmRNSTotal Voting Rights
18th Dec 20198:49 amRNSHolding(s) in Company
6th Dec 20193:01 pmRNSDirector/PDMR Shareholding
6th Dec 20192:40 pmRNSDirector/PDMR Shareholding
4th Dec 20197:00 amRNSAcquisition of Moorfield Nanotechnology Limited
21st Nov 20197:00 amRNSSpecial dividend

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.